BAATAF
Boston Area Anticoagulation Trial for Atrial Fibrillation

Purpose
To assess the efficacy of low-dose warfarin in preventing strokes in patients with NRAF

References
The Boston Area Anticoagulation Trial for Atrial Fibrillation investigators: The effect of low-dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation. N Engl J Med 1990, 323:1505–1511.
Singer DE, Hughes RA, Gress DR,
et al: The effect of aspirin on the risk of stroke in patients with nonrheumatic atrial fibrillation: the BAATAF study. Am Heart J 1992, 124:1567–1573.
Kistler JP, Singer DE, Millenson MM,
et al: Effect of low-intensity warfarin anticoagulation on level of activity of the hemostatic system in patients with atrial fibrillation. Stroke 1993, 24:1360–1365.

Apoio: Libbs Farmacêutica Farmacêutica